UK markets open in 7 hours 36 minutes

Arcus Biosciences, Inc. (RCUS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
16.78-0.12 (-0.71%)
At close: 04:00PM EDT
16.55 -0.23 (-1.37%)
After hours: 06:49PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
127,000
206,000
148,000
173,415
Other short-term investments
632,000
803,000
351,000
555,231
Total cash
759,000
1,009,000
499,000
728,646
Net receivables
38,000
39,000
745,000
1,049
Other current assets
30,000
15,000
16,000
5,471
Total current assets
831,000
1,067,000
1,262,000
735,815
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
82,000
58,000
50,000
37,876
Accumulated depreciation
-31,000
-23,000
-18,000
-14,288
Net property, plant and equipment
51,000
35,000
32,000
23,588
Equity and other investments
107,000
129,000
182,000
6,440
Other long-term assets
106,000
114,000
116,000
6,449
Total non-current assets
264,000
278,000
330,000
36,477
Total assets
1,095,000
1,345,000
1,592,000
772,292
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
17,000
20,000
10,000
15,682
Taxes payable
-
0
2,000
0
Accrued liabilities
62,000
70,000
52,000
27,850
Deferred revenues
91,000
97,000
102,000
74,571
Other current liabilities
3,000
3,000
52
3,566
Total current liabilities
184,000
193,000
166,000
121,669
Non-current liabilities
Deferred revenues
307,000
355,000
462,000
132,533
Other long-term liabilities
142,000
140,000
122,000
543
Total non-current liabilities
449,000
495,000
584,000
148,319
Total liabilities
633,000
688,000
750,000
269,988
Stockholders' equity
Common stock
1,311,000
1,206,000
1,118,000
6
Retained earnings
-849,000
-542,000
-275,000
-328,184
Accumulated other comprehensive income
0
-7,000
-1,000
44
Total stockholders' equity
462,000
657,000
842,000
502,304
Total liabilities and stockholders' equity
1,095,000
1,345,000
1,592,000
772,292